Education
About Us
Working with TipRanks
Follow Us
Nanosonics Limited (AU:NAN)
ASX:NAN
NAN Stock Chart & Stats
AU$3.28
AU$0.07(2.30%)
At close: 4:00 PM EST
AU$3.28
AU$0.07(2.30%)
Day’s Range― - ―
52-Week RangeAU$3.21 - AU$5.18
Previous CloseN/A
Volume330.71K
Average Volume (3M)506.11K
Market Cap
AU$994.97M
Enterprise ValueAU$845.03M
Total Cash (Recent Filing)AU$159.83M
Total Debt (Recent Filing)AU$9.88M
Price to Earnings (P/E)48.4
Beta0.48
Next Earnings
Sep 01, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding303,346,040
10 Day Avg. Volume525,818
30 Day Avg. Volume506,110
Financial Highlights & Ratios
PEG Ratio0.95
Price to Book (P/B)5.85
Price to Sales (P/S)6.18
P/FCF Ratio34.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$4.20Price Target Upside27.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring Consumables RevenueA strong razor-and-blades model with recurring consumables growing ~9% YoY creates durable, usage-driven revenue. An expanding installed base converts one-off device placements into high-margin, predictable cash flows that scale with procedure volumes and provide long-term revenue visibility.
High Gross MarginsSustained high gross margins reflect proprietary chemistry, consumable economics and limited direct commodity exposure. Persistent margin headroom supports reinvestment in R&D and commercialization, cushioning profit sustainability even with occasional freight or tariff pressures.
Strong Balance Sheet & Cash GenerationA debt-free balance sheet, sizable cash reserves and materially improving free cash flow provide financial optionality to fund CORIS commercialization, capex and working-capital needs without sacrificing operational stability, reducing refinancing and liquidity risk over the medium term.
Bears Say
Margin Pressure From Tariffs & FreightStructural exposure to tariffs, air freight and product-mix shifts can persistently compress gross margins if global logistics or trade policies remain adverse. While core margins are high, sustained cost inflation or tariff volatility could erode unit economics and require pricing or cost actions to restore margins.
Moderating Average Selling PricesA shift toward high-volume upgrade deals and lower-ASP models can structurally reduce one-off capital revenue per installation. Over time this may cap capital-sales growth and put pressure on capital-related margin contribution, forcing reliance on recurring consumables to sustain overall revenue growth.
CORIS Commercialization & Near-term InvestmentCommercializing CORIS requires upfront inventory, higher OpEx and phased market launches, creating execution and timing risk. If adoption lags or regulatory/launch costs extend, near-term cash outflows and profit dilution could persist despite a strong balance sheet, delaying expected revenue payback.
Nanosonics Limited News
NAN FAQ
What was Nanosonics Limited’s price range in the past 12 months?
Nanosonics Limited lowest share price was AU$3.21 and its highest was AU$5.18 in the past 12 months.
What is Nanosonics Limited’s market cap?
Nanosonics Limited’s market cap is AU$994.97M.
When is Nanosonics Limited’s upcoming earnings report date?
Nanosonics Limited’s upcoming earnings report date is Sep 01, 2026 which is in 187 days.
How were Nanosonics Limited’s earnings last quarter?
Nanosonics Limited released its earnings results on Feb 23, 2026. The company reported AU$0.031 earnings per share for the quarter, the consensus estimate of AU$0.031 by AU$0.
Is Nanosonics Limited overvalued?
According to Wall Street analysts Nanosonics Limited’s price is currently Undervalued.
Does Nanosonics Limited pay dividends?
Nanosonics Limited does not currently pay dividends.
What is Nanosonics Limited’s EPS estimate?
Nanosonics Limited’s EPS estimate is 0.03.
How many shares outstanding does Nanosonics Limited have?
Nanosonics Limited has 303,346,040 shares outstanding.
What happened to Nanosonics Limited’s price movement after its last earnings report?
Nanosonics Limited reported an EPS of AU$0.031 in its last earnings report, expectations of AU$0.031. Following the earnings report the stock price went down -9.89%.
Which hedge fund is a major shareholder of Nanosonics Limited?
Currently, no hedge funds are holding shares in AU:NAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nanosonics Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$4.20 (27.90% Upside)
AU$4.20 (27.90% Upside)
Blogger Sentiment
Bullish
AU:NAN Sentiment 75%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
49.48%
12-Months-Change
Fundamentals
Return on Equity
10.32%
Trailing 12-Months
Asset Growth
11.93%
Trailing 12-Months
Company Description
Nanosonics Limited
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
NAN Company Deck
NAN Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a substantially positive operational and financial picture: revenue and recurring revenue grew ~9% YoY, operating margin expanded materially (27%) with tight OpEx control, installed base and installations (20%) increased, and CORIS reached important regulatory and controlled release milestones. Headwinds cited were mostly external or transitional — FX volatility caused reported EBIT/PBT to dip slightly, gross margins were modestly compressed by tariffs, airfreight and product mix, and CORIS commercialization is driving incremental OpEx and near-term inventory investment. Overall, the company reaffirmed FY26 guidance (8–12% revenue growth at constant currency) and conveyed clear execution plans and balance-sheet strength, leaving the balance of information as net positive.View all AU:NAN earnings summariesNAN Stock 12 Month Forecast
Average Price Target
AU$4.20
▲(27.90% Upside)
Technical Analysis
SDI Limited
―
Austco Healthcare Limited
―
Cyclopharm Limited
―
Trajan Group Holdings Ltd
―
Aroa Biosurgery Ltd
―
Options Prices
Currently, No data available
---